Ppar-γ agonist pioglitazone prevents apoptosis of endothelial progenitor cells from rat bone marrow

Cell Biology International

Volumn 37, Issue 5, 2013, Pages 430-435

  Zhang, Hui Feng ^a   Wang, Li ^a   Yuan, Hui Juan ^a   Ma, Yue Hua ^a   Wang, Yan Fang ^a   Hu, Zi Ying ^a   Su, Yong ^a   Zhao, Zhi Gang ^a  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Apoptosis; Endothelial progenitor cells; PI3K AKT; Pioglitazone

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PIOGLITAZONE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; BONE MARROW; CELL PROLIFERATION; CELL PROTECTION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; FLUORESCENCE; MALE; MOLECULAR MECHANICS; NONHUMAN; RAT; SIGNAL TRANSDUCTION;

EID: 84878138746     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10046     Document Type: Article

References (27)

1. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, Dimmeler S (2003) Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9: 1370-6.
2. Aicher A, Zeiher AM, Dimmeler S (2005) Mobilizing endothelial progenitor cells. Hypertension 45: 321-5.
3. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-7.
4. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-8.
5. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-76.
6. Bolten CW, Payne MA, McDonald WG, Blanner PM, Chott RC, Ghosh S, Arhancet GB, Staten NR, Gulve EA, Sullivan PM, Hromockyj AE, Colca JR (2007) Thiazolidinediones inhibit the progression of established hypertension in the Dahl saltsensitive rat. Diab Vasc Dis Res 4: 117-23.
7. Christoph G, Clever YP,Werner C,Hanhoun M, Böhm M, Laufs U (2007) The PPAR-γ agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells. Atherosclerosis 192: 67-74.
8. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rütten H, Fichtlscherer S, Martin H, Zeiher AM (2001) HMG-CoA reductasehinhibitors (statins; increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108: 391-7.
9. Hetzel J, Balletshofer B, Rittig K,Walcher D, KratzerW, Hombach V, Häring HU, Koenig W, Marx N (2005) Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers. Arterioscler Thromb Vasc Biol 25: 1804-9.
10. Hill JM, Zalos GHalcox JP, Schenke WH,WaclawiwMA, Quyyumi AA, Finkel T (2003) Circulating endothelial progenitor cells vascular function and cardiovascular risk. N Engl J Med 348: 593-600.
11. Horio T, Suzuki M, Takamisawa I, Suzuki K, Hiuge A, Yoshimasa Y, Kawano Y (2005) Pioglitazone-induced insulin sensitization improves vascular endothelial function in nondiabetic patients with essential hypertension. Am J Hypertens 18: 1626-30.
12. Ikeda U, Shimpo M, Murakami Y, Shimada K (2000) Peroxisome proliferator-activated receptor-gamma ligands inhibit nitric oxide synthesis in vascular smooth muscle cells. Hypertension 35: 1232-6.
13. Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD (2001) Cellular function of phosphoinositide 3-kinases: implications for development homeostasis and cancer. Annu Rev Cell Dev Biol 17: 615-75.
14. Llevadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A, Walsh K, Isner JM, Asahara T (2001) HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 108: 399-405.
15. Marx N, Wohrle J, Nusser T, Walcher D, Rinker A, Hombach V, Koenig W, Höher M (2005) Pioglitazone reduces neointima volume after coronary stent implantation: a randomized placebo-controlled double-blind trial in nondiabetic patients. Circulation 112: 2792-8.
16. Onuts G, Rienstra H, de Boer JF, Boer MW, Roks AJ, Klatter FA, Uges DR, Navis G, Rozing J, Hillebrands JL (2007) Rosiglitazone attenuates transplant arteriosclerosis after allogeneic aorta transplantation in rats. Transplantion 84: 517-26.
17. Pfutzner A, Marx N, Lubben G, Langenfeld M,Walcher D, Konrad T, Forst T (2005) Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer study. J Am Coll Cardiol 45: 1925-31.
18. Pistrosch F, Passauer J, Fischer S, Fuecker K, Hanefeld M, Gross P (2004) In type 2 diabetes rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control. Diabetes Care 27: 484-90.
19. Rafii S, Lyden D (2003) Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9: 702-12.
20. Strehlow K, Werner N, Berweiler J, Link A, Dirnagl U, Priller J, Laufs K, Ghaeni L, Milosevic M, Böhm M, Nickenig G (2003) Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107: 3059-65.
21. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T, Nishimura H, Losordo DW, Asahara T, Isner JM (2002) Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bonemarrow-derived endothelial progenitor cells. Circulation 105: 3017-24.
22. Wang CH, Ciliberti N, Li SH, Szmitko PE, Weisel RD, Fedak PW, Al-Omran M, Cherng WJ, Li RK, StanfordWL, Verma S (2004) Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Circulation 109: 1392-400.
23. Ward SG, Finan P (2003) Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents. Curr Opin Pharmacol 3: 426-34.
24. Wei B,Han XY,Qi CL, Zhang S, Zheng ZH,Huang Y, Chen TF,Wei HB (2012) Coaction of spheroid-derived stem-like cells and endothelial progenitor cells promotes development of colon cancer. PLoS ONE 7: 39069.
25. Werner N, Junk S, Laufs U, Link A,Walenta K, Bohm M, Nickenig G (2003) Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93: 17-24.
26. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364: 141-8.
27. Yang N, Li D, Jiao P, Chen B, Yao S, Sang H, Yang M, Han J, Zhang Y, Qin S (2011) The characteristics of endothelial progenitor cells derived from mononuclear cells of rat bone marrow in different culture conditions. Cytotechnology 63: 217-26.